title: Desogestrel: using a selective progestogen in a combined oral contraceptive.
abstract: Desogestrel is the most selective progestogen used in oral contraceptives (OCs). The clinical characteristics of the monophasic combined OC containing 150 micrograms desogestrel and 30 micrograms EE per tablet (Marvelon) are in accordance with the strong progestogenic and minimal androgenic effects of desogestrel: a very high contraceptive efficacy is combined with minimal and, in the case of lipid metabolism, even potentially positive effects on metabolic parameters. Through increasing the plasma levels of sex hormone binding globulin, and thereby decreasing the plasma levels of free testosterone, the desogestrel-containing OC also has substantial beneficial effects on acne.
authors.affiliation: Medical Services Department, Organon International BV, Oss, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: op ten Berg
mesh_terms: D003277:Contraceptives, Oral, Combined / Q000009:adverse effects / Q000737:chemistry / Q000592:standards / Q000627:therapeutic use*; D017135:Desogestrel; D005260:Female; D006801:Humans; D009652:Norpregnenes / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D011372:Progestins / Q000032:analysis
chemical_list: D003277:Contraceptives, Oral, Combined; D009652:Norpregnenes; D011372:Progestins; D017135:Desogestrel